2019-07-09 15:14:00 Tue ET
stock market competition macrofinance stock return s&p 500 financial crisis financial deregulation bank oligarchy systemic risk asset market stabilization asset price fluctuations regulation capital financial stability dodd-frank
The Chinese new star board launches for tech firms to list at home. The Nasdaq-equivalent new star board serves as a key avenue for Chinese tech companies to raise funds as the stock exchange criteria are less stringent than other domestic boards. In recent years, the Chinese government encourages local tech firms to become more self-reliant in producing microchips and other core components. This new star board arises amid the current Sino-American trade escalation and recent U.S. embargo on the HuaWei supply chain of electronic imports.
As of mid-2019, the new star board has received applications from 122 tech firms. Tech companies with at least RMB$300 million ($43 million) net income can list on the new star board insofar as these companies maintain the minimum stock market capitalization of RMB$2 billion with RMB$100 million cash flows in the prior 3 years. The board is the first registration-driven IPO system that streamlines price flotation restrictions. Like Facebook, Google, Alibaba, and JD etc, Chinese tech companies with a dual-class shareholding structure are eligible to apply for public registration. Alibaba has to mull over its recent proposal to list on Hong Kong Stock Exchange several years after its blockbuster IPO on NYSE.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.
2018-10-15 09:33:00 Monday ET
Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties such as cardiovascular medications an
2020-10-06 09:31:00 Tuesday ET
Strategic managers envision lofty purposes to enjoy incremental consistent progress over time. Allison Rimm (2015) The joy of strategy: a bu
2024-05-05 10:31:00 Sunday ET
Stock Synopsis: Pharmaceutical post-pandemic patent development cycle In terms of stock market valuation, the major pharmaceutical sector remains at its
2019-12-04 14:35:00 Wednesday ET
Many billionaires choose to live below their means with frugal habits and lifestyles. Those people who consistently commit to saving more, spending less, an
2018-10-23 12:36:00 Tuesday ET
Former Fed Chair Paul Volcker releases his memoir, talks about American public governance, and worries about plutocracy in America. Volcker suggests that pu
2018-12-21 11:39:00 Friday ET
The Internet and telecom conglomerate SoftBank Group raises $23 billion in the biggest IPO in Japan. Going public is part of the major corporate move away f